Aquestive Therapeutics (AQST) Return on Sales [ROS] (2017 - 2026)
Aquestive Therapeutics' Return on Sales [ROS] was -191.46% in Q3 2026, down 101.83 percentage points from -89.63% a year earlier and down 131.96 percentage points from the prior quarter.
Aquestive Therapeutics (AQST) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aquestive Therapeutics' Return on Sales [ROS] was -114.12% through Sep 30, 2026, up 14.44 percentage points year-over-year; for FY2025, it came in at -159.50%, down 106.05 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -65.95 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was -53.46% in FY2024 (-23.60 pp), -29.86% in FY2023 (+58.37 pp), -88.23% in FY2022 (-20.00 pp) and -68.22% in FY2021 (+25.33 pp).
- Quarterly Return on Sales [ROS] has moved between -222.08% (Q1 2025) and 0.27% (Q2 2024) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last eight quarters, with an average year-over-year change of -42.10 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2026 (a gain of 192.97 percentage points); the worst was Q1 2025 (a drop of 147.76 percentage points).
- Per Business Quant data, AQST's Return on Sales [ROS] in the three quarters before Q3 2026 was -59.51% (Q2 2026), -29.10% (Q1 2026) and -221.58% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn | -191.46% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -191.46% |
| Jun 30, 2026 | -59.51% |
| Mar 31, 2026 | -29.10% |
| Dec 31, 2025 | -221.58% |
| Sep 30, 2025 | -89.63% |
| Jun 30, 2025 | -113.65% |
| Mar 31, 2025 | -222.08% |
| Dec 31, 2024 | -114.43% |
| Sep 30, 2024 | -61.22% |
| Jun 30, 2024 | 0.27% |
| Mar 31, 2024 | -74.31% |
| Dec 31, 2023 | -29.62% |
| Sep 30, 2023 | -18.28% |
| Jun 30, 2023 | -31.79% |
| Mar 31, 2023 | -41.36% |
| Dec 31, 2022 | -100.29% |
| Sep 30, 2022 | -77.23% |
| Jun 30, 2022 | -96.21% |
| Mar 31, 2022 | -79.36% |
| Dec 31, 2021 | -105.33% |
Aquestive Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();